Home

In ekipa Trdnjava Prekoračitev cardiac markers aha poslan Obvezno argument

Biomarkers in Acute Cardiac Disease: The Present and the Future -  ScienceDirect
Biomarkers in Acute Cardiac Disease: The Present and the Future - ScienceDirect

Cardiac natriuretic hormones as clinical markers: instructions for use |  Future Cardiology
Cardiac natriuretic hormones as clinical markers: instructions for use | Future Cardiology

Cardiac biomarkers: a contemporary status report | Nature Reviews Cardiology
Cardiac biomarkers: a contemporary status report | Nature Reviews Cardiology

Biomarkers in Routine Heart Failure Clinical Care
Biomarkers in Routine Heart Failure Clinical Care

Cardiac Marker - an overview | ScienceDirect Topics
Cardiac Marker - an overview | ScienceDirect Topics

Established and Emerging Roles of Biomarkers in Heart Failure | Circulation  Research
Established and Emerging Roles of Biomarkers in Heart Failure | Circulation Research

Frontiers | A Review of Biomarkers for Ischemic Stroke Evaluation in  Patients With Non-valvular Atrial Fibrillation
Frontiers | A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation

Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and  Cardiovascular Diseases | Metabolic Syndrome and Related Disorders
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases | Metabolic Syndrome and Related Disorders

VIDAS ® Troponin I Ultra - Understanding Your Concerns | bioMérieux  Clinical Diagnostics
VIDAS ® Troponin I Ultra - Understanding Your Concerns | bioMérieux Clinical Diagnostics

JCM | Free Full-Text | Cardiac Biomarkers in the Emergency Department: The  Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary  Syndrome—There is Meat on the Bone
JCM | Free Full-Text | Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone

Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline,  Cerebrovascular Disease, and Clinical Events | Stroke
Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events | Stroke

Salivary biomarkers in cardiovascular disease: An insight into the current  evidence - Bahbah - 2021 - The FEBS Journal - Wiley Online Library
Salivary biomarkers in cardiovascular disease: An insight into the current evidence - Bahbah - 2021 - The FEBS Journal - Wiley Online Library

Cardiac Biomarkers: How to Use Them Wisely | 2010-01-18 | AHC Media:…
Cardiac Biomarkers: How to Use Them Wisely | 2010-01-18 | AHC Media:…

Unstable Angina Workup: Approach Considerations, Basic Blood Studies, Cardiac  Biomarkers
Unstable Angina Workup: Approach Considerations, Basic Blood Studies, Cardiac Biomarkers

ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison |  Journal of the American College of Cardiology
ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison | Journal of the American College of Cardiology

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and  Validation of the ABC Stroke Score Over Time | Journal of the American  Heart Association
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time | Journal of the American Heart Association

Cardiac Marker - an overview | ScienceDirect Topics
Cardiac Marker - an overview | ScienceDirect Topics

Intermittent fasting may protect the heart by controlling inflammation | American  Heart Association
Intermittent fasting may protect the heart by controlling inflammation | American Heart Association

Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis  and Ischemia, Acute Coronary Syndrome Testing Strategy
Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy

Cardiac Biomarkers for Myocardial Infarction I. Policy Description II.  Related Policies III. Indications and/or Limitations of C
Cardiac Biomarkers for Myocardial Infarction I. Policy Description II. Related Policies III. Indications and/or Limitations of C

Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and  Cardiovascular Diseases | Metabolic Syndrome and Related Disorders
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases | Metabolic Syndrome and Related Disorders